Hubei Biocause Heilen Pharmaceutical Co.,Ltd.
百科亨迪
Hubei Biocause Heilen Pharmaceutical Co.,Ltd.
Biotech/Healthcare
Hubei Biocause Heilen Pharmaceutical Co., Ltd. develops, manufactures, and sells chemical active pharmaceutical ingredients and finished formulations.
Latest round: Post-IPO (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-03-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.